Search research articles
Contact Us
Filters
Showing results (501-510 of 524) with videos related to
Page
of 53
Sort By:
Contemporary Clinical Trials
|
September 13, 2012
The MeTeOR trial (Meniscal Tear in Osteoarthritis Research): rationale and design features
Jeffrey N Katz, Christine E Chaisson, Brian Cole, et al.
European Heart Journal
|
October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
Frank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.
The New England Journal of Medicine
|
December 14, 2016
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E Nissen, Neville D Yeomans, Daniel H Solomon, et al.
Pharmacoepidemiology and Drug Safety
|
September 16, 2011
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems
Lisa J Herrinton, Jeffrey R Curtis, Lang Chen, et al.
ACR Open Rheumatology
|
May 1, 2021
Designing a Strategy Trial for the Management of Gout: The Use of a Modified Delphi Panel
Daniel H Solomon, Joel S Weissman, Hyon Choi, et al.
Annals of the Rheumatic Diseases
|
August 22, 2023
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2016
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
Steven R Cummings, Felicia Cosman, E Michael Lewiecki, et al.
JAMA Internal Medicine
|
August 8, 2018
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial
Niteesh K Choudhry, Thomas Isaac, Julie C Lauffenburger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 28, 2025
3-year Results of Tapering TNFi to Withdrawal Compared to Stable TNFi Among Patients with Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Rheumatology (Oxford, England)
|
July 31, 2012
Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis
Helena Canhão, Ana Maria Rodrigues, Ana Filipa Mourão, et al.
Page
of 53
Search research articles
Search
Showing results (501-510 of 524) with videos related to
Sort By:
Page
of 53
Contemporary Clinical Trials
|
September 13, 2012
The MeTeOR trial (Meniscal Tear in Osteoarthritis Research): rationale and design features
Jeffrey N Katz, Christine E Chaisson, Brian Cole, et al.
European Heart Journal
|
October 12, 2017
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
Frank Ruschitzka, Jeffrey S Borer, Henry Krum, et al.
The New England Journal of Medicine
|
December 14, 2016
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E Nissen, Neville D Yeomans, Daniel H Solomon, et al.
Pharmacoepidemiology and Drug Safety
|
September 16, 2011
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems
Lisa J Herrinton, Jeffrey R Curtis, Lang Chen, et al.
ACR Open Rheumatology
|
May 1, 2021
Designing a Strategy Trial for the Management of Gout: The Use of a Modified Delphi Panel
Daniel H Solomon, Joel S Weissman, Hyon Choi, et al.
Annals of the Rheumatic Diseases
|
August 22, 2023
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 20, 2016
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
Steven R Cummings, Felicia Cosman, E Michael Lewiecki, et al.
JAMA Internal Medicine
|
August 8, 2018
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial
Niteesh K Choudhry, Thomas Isaac, Julie C Lauffenburger, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 28, 2025
3-year Results of Tapering TNFi to Withdrawal Compared to Stable TNFi Among Patients with Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, et al.
Rheumatology (Oxford, England)
|
July 31, 2012
Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis
Helena Canhão, Ana Maria Rodrigues, Ana Filipa Mourão, et al.
Page
of 53